NCT04869202

Brief Summary

Prospective study of both maternal and fetal outcomes of those pregnancies that were complicated by COVID-19 infection at various gestational ages. The follow up will be from the time the diagnosis was made till discharge of the mother and her baby from the hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
224

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 29, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 3, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2022

Completed
Last Updated

June 18, 2023

Status Verified

June 1, 2023

Enrollment Period

12 months

First QC Date

April 29, 2021

Last Update Submit

June 13, 2023

Conditions

Perinatology

Outcome Measures

Primary Outcomes (1)

  • feto-maternal outcome

    fetal and maternal consequences of the infection

    1 year

Interventions

COVID-19 testDIAGNOSTIC_TEST

Naso-pharyngeal swab test

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women infected with COVID-19
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women who contract COVID-19 virus infection during pregnancy

You may qualify if:

  • pregnant women

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jordan University Hospital

Amman, Jordan

Location

Study Officials

  • Asma Basha

    The University of Jordan

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 29, 2021

First Posted

May 3, 2021

Study Start

December 1, 2020

Primary Completion

November 30, 2021

Study Completion

January 30, 2022

Last Updated

June 18, 2023

Record last verified: 2023-06

Locations

JO(1)